Key result
Endothelial cells produce a lipoxygenase metabolite (LOX) that, along with PGI2, decreases platelet adhesion to endothelial cells and thrombogenic surfaces.
Endothelial cells produce a lipoxygenase-derived metabolite that, alongside PGI2, acts to repel platelets and decrease adhesion, providing insight into platelet-endothelial interactions.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for endothelial anti-adhesive mechanisms; validation in human models required before clinical relevance.
We performed experiments to determine whether endothelial cells synthesize phospholipid metabolites via the lipoxygenase pathway and whether these metabolites influence platelet/vessel wall interactions. Monolayers of cultured human endothelial cells were incubated with 14C-arachidonic acid and their cyclo-oxygenase and lipoxygenase metabolites were extracted and identified by radioimmunoassay, thin layer chromatography and high performance liquid chromatography. We found that in addition to the membrane-associated production of PGI2, endothelial cells synthesized a cytosol-associated metabolite, LOX, which was presumably derived through the lipoxygenase pathway. Inhibition of LOX was associated with an increase in PGI2 production and inhibition of PGI2 with an increase in LOX production. Under either condition, platelet adhesion to cultured endothelial cells was significantly decreased. In contrast, when both PGI2 and LOX production were inhibited, platelet adhesion to endothelial cells was enhanced. Furthermore, when LOX was bound to a thrombogenic surface, platelet adhesion was significantly decreased whereas when arachidonic acid or 12-HETE was bound to the surface, platelet adhesion was increased. We conclude that endothelial cells produce not only a cyclo-oxygenase metabolite, but also a lipoxygenase metabolite, both of which influence platelet/endothelial cell interactions.
No takes yet. Share an insight, caveat, or question.
Buchanan et al. (1985) studied this question. Inhibition of LOX and/or PGI2 was evaluated on Platelet adhesion to cultured endothelial cells. Endothelial cells produce a lipoxygenase metabolite (LOX) that, along with PGI2, decreases platelet adhesion to endothelial cells and thrombogenic surfaces.
Synapse has enriched 10 related papers. Consider them for comparative context: